Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients

Ozdemir, N.; Aksoy, S.; Sendur, M.; Akinci, M.; Yazici, O.; Budakoglu, B.; Abali, H.; Oksuzoglu, B.; Zengin, N.

Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients

Ozdemir N., Aksoy S., Sendur M. A. N., Akinci M. B., Yazici O., Budakoglu B., ...Daha Fazla

JOURNAL OF BUON, cilt.18, sa.4, ss.831-837, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 4
Basım Tarihi: 2013
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.831-837
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the activity and toxicity of the combination of capecitabine and cisplatin (CapCisp) in anthracycline- and taxane-pretreated HER-2 negative metastatic breast carcinoma (MBC) female patients.